GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (FRA:1AD1) » Definitions » Cyclically Adjusted PS Ratio

AddLife AB (FRA:1AD1) Cyclically Adjusted PS Ratio : 3.31 (As of Jun. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is AddLife AB Cyclically Adjusted PS Ratio?

As of today (2025-06-02), AddLife AB's current share price is €16.76. AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €5.06. AddLife AB's Cyclically Adjusted PS Ratio for today is 3.31.

The historical rank and industry rank for AddLife AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:1AD1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.97   Med: 2.76   Max: 3.43
Current: 3.34

During the past years, AddLife AB's highest Cyclically Adjusted PS Ratio was 3.43. The lowest was 1.97. And the median was 2.76.

FRA:1AD1's Cyclically Adjusted PS Ratio is ranked worse than
60.87% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs FRA:1AD1: 3.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AddLife AB's adjusted revenue per share data for the three months ended in Mar. 2025 was €2.024. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €5.06 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


AddLife AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AddLife AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB Cyclically Adjusted PS Ratio Chart

AddLife AB Annual Data
Trend Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.57

AddLife AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.25 2.47 3.16 2.57 2.63

Competitive Comparison of AddLife AB's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted PS Ratio falls into.


;
;

AddLife AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AddLife AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.76/5.06
=3.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, AddLife AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.024/132.8245*132.8245
=2.024

Current CPI (Mar. 2025) = 132.8245.

AddLife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.431 99.995 0.573
201509 0.477 100.228 0.632
201512 0.617 100.276 0.817
201603 0.537 100.751 0.708
201606 0.513 101.019 0.675
201609 0.413 101.138 0.542
201612 0.614 102.022 0.799
201703 0.589 102.022 0.767
201706 0.572 102.752 0.739
201709 0.529 103.279 0.680
201712 0.659 103.793 0.843
201803 0.579 103.962 0.740
201806 0.596 104.875 0.755
201809 0.549 105.679 0.690
201812 0.677 105.912 0.849
201903 0.754 105.886 0.946
201906 0.703 106.742 0.875
201909 0.667 107.214 0.826
201912 0.840 107.766 1.035
202003 0.860 106.563 1.072
202006 1.060 107.498 1.310
202009 1.060 107.635 1.308
202012 1.482 108.296 1.818
202103 1.511 108.360 1.852
202106 1.856 108.928 2.263
202109 1.492 110.338 1.796
202112 1.674 112.486 1.977
202203 2.010 114.825 2.325
202206 1.610 118.384 1.806
202209 1.588 122.296 1.725
202212 1.697 126.365 1.784
202303 1.788 127.042 1.869
202306 1.663 129.407 1.707
202309 1.609 130.224 1.641
202312 1.866 131.912 1.879
202403 1.864 132.205 1.873
202406 1.857 132.716 1.859
202409 1.694 132.304 1.701
202412 2.010 132.987 2.008
202503 2.024 132.825 2.024

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AddLife AB  (FRA:1AD1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AddLife AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AddLife AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals and laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB Headlines

No Headlines